New Drug to Prevent Migraine May Start Working in Days

A new drug to prevent migraine called TEV-48125 was associated with fewer headache hours for people with chronic migraine within three to seven days after the first injection, according to a study published in the June 8th, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. Chronic migraine is defined… Continue reading New Drug to Prevent Migraine May Start Working in Days

Hope for New Migraine Prevention Drugs

Migraine researchers and clinicians are growing excited about a new class of drugs called Calcitonin Gene-Related Peptide (CGRP) monoclonal antibodies, which are showing promise in treating high-frequency episodic migraine and chronic migraine. A release from the American Headache Society quotes Peter J. Goadsby, MD, PhD, chair of the scientific program of the American Headache Society’s… Continue reading Hope for New Migraine Prevention Drugs